Drugs / EnvDNA
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00623753 | May 2007 → Jan 2008 | HIV infectious disease | St. Jude Children's Research Hospital | Terminated | No outcome recorded |
| Phase 1 | NCT00187148 | Feb 2005 → Nov 2009 | HIV infectious disease | St. Jude Children's Research Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EnvDNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00187148 ↗ |
| Modality | Vaccine | “The vaccine that will be tested in this study was made from the information that the virus uses to make a small part of the HIV.” NCT00187148 ↗ |
| Route | Intramuscular | “Once the DNA is injected intramuscularly, it should tell cells to make the envelope protein.” NCT00187148 ↗ |